Logo image of BV

BRIGHTVIEW HOLDINGS INC (BV) Stock Fundamental Analysis

NYSE:BV - US10948C1071 - Common Stock

14.84 USD
+0.23 (+1.57%)
Last: 8/27/2025, 8:04:01 PM
14.84 USD
0 (0%)
After Hours: 8/27/2025, 8:04:01 PM
Fundamental Rating

3

Taking everything into account, BV scores 3 out of 10 in our fundamental rating. BV was compared to 84 industry peers in the Commercial Services & Supplies industry. BV has a bad profitability rating. Also its financial health evaluation is rather negative. BV is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year BV was profitable.
BV had a positive operating cash flow in the past year.
In multiple years BV reported negative net income over the last 5 years.
BV had a positive operating cash flow in each of the past 5 years.
BV Yearly Net Income VS EBIT VS OCF VS FCFBV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M 200M

1.2 Ratios

BV has a Return On Assets (0.21%) which is comparable to the rest of the industry.
BV has a Return On Equity (0.39%) which is in line with its industry peers.
BV has a Return On Invested Capital of 3.13%. This is comparable to the rest of the industry: BV outperforms 45.24% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BV is significantly below the industry average of 10.78%.
The 3 year average ROIC (2.40%) for BV is below the current ROIC(3.13%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.21%
ROE 0.39%
ROIC 3.13%
ROA(3y)0.26%
ROA(5y)0.17%
ROE(3y)0.6%
ROE(5y)0.4%
ROIC(3y)2.4%
ROIC(5y)2.06%
BV Yearly ROA, ROE, ROICBV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 -4 -6

1.3 Margins

With a Profit Margin value of 0.26%, BV perfoms like the industry average, outperforming 45.24% of the companies in the same industry.
In the last couple of years the Profit Margin of BV has declined.
BV has a Operating Margin (4.88%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of BV has declined.
BV has a worse Gross Margin (23.25%) than 65.48% of its industry peers.
In the last couple of years the Gross Margin of BV has declined.
Industry RankSector Rank
OM 4.88%
PM (TTM) 0.26%
GM 23.25%
OM growth 3Y4.93%
OM growth 5Y-5.36%
PM growth 3Y-27.02%
PM growth 5Y-17.52%
GM growth 3Y-2.9%
GM growth 5Y-2.54%
BV Yearly Profit, Operating, Gross MarginsBV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

3

2. Health

2.1 Basic Checks

BV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, BV has more shares outstanding
The number of shares outstanding for BV has been reduced compared to 5 years ago.
Compared to 1 year ago, BV has an improved debt to assets ratio.
BV Yearly Shares OutstandingBV Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BV Yearly Total Debt VS Total AssetsBV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 1.50, we must say that BV is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of BV (1.50) is worse than 67.86% of its industry peers.
The Debt to FCF ratio of BV is 24.18, which is on the high side as it means it would take BV, 24.18 years of fcf income to pay off all of its debts.
BV has a Debt to FCF ratio (24.18) which is in line with its industry peers.
BV has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
BV has a Debt to Equity ratio (0.44) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 24.18
Altman-Z 1.5
ROIC/WACC0.38
WACC8.24%
BV Yearly LT Debt VS Equity VS FCFBV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

BV has a Current Ratio of 1.31. This is a normal value and indicates that BV is financially healthy and should not expect problems in meeting its short term obligations.
BV's Current ratio of 1.31 is on the low side compared to the rest of the industry. BV is outperformed by 65.48% of its industry peers.
A Quick Ratio of 1.31 indicates that BV should not have too much problems paying its short term obligations.
BV's Quick ratio of 1.31 is in line compared to the rest of the industry. BV outperforms 47.62% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.31
BV Yearly Current Assets VS Current LiabilitesBV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

BV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.88%, which is quite impressive.
Measured over the past years, BV shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.19% on average per year.
Looking at the last year, BV shows a decrease in Revenue. The Revenue has decreased by -2.99% in the last year.
BV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.85% yearly.
EPS 1Y (TTM)21.88%
EPS 3Y-14.5%
EPS 5Y-8.19%
EPS Q2Q%-6.25%
Revenue 1Y (TTM)-2.99%
Revenue growth 3Y2.71%
Revenue growth 5Y2.85%
Sales Q2Q%-4.13%

3.2 Future

The Earnings Per Share is expected to grow by 12.15% on average over the next years. This is quite good.
The Revenue is expected to grow by 1.47% on average over the next years.
EPS Next Y9.87%
EPS Next 2Y8.93%
EPS Next 3Y12.15%
EPS Next 5YN/A
Revenue Next Year-2.64%
Revenue Next 2Y-0.3%
Revenue Next 3Y1.47%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BV Yearly Revenue VS EstimatesBV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
BV Yearly EPS VS EstimatesBV Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 19.03, BV is valued on the expensive side.
Based on the Price/Earnings ratio, BV is valued a bit cheaper than 69.05% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.14, BV is valued a bit cheaper.
With a Price/Forward Earnings ratio of 16.68, BV is valued correctly.
Based on the Price/Forward Earnings ratio, BV is valued a bit cheaper than the industry average as 71.43% of the companies are valued more expensively.
BV is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.80, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 19.03
Fwd PE 16.68
BV Price Earnings VS Forward Price EarningsBV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

86.90% of the companies in the same industry are more expensive than BV, based on the Enterprise Value to EBITDA ratio.
BV's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 43.07
EV/EBITDA 7.18
BV Per share dataBV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BV does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as BV's earnings are expected to grow with 12.15% in the coming years.
PEG (NY)1.93
PEG (5Y)N/A
EPS Next 2Y8.93%
EPS Next 3Y12.15%

0

5. Dividend

5.1 Amount

No dividends for BV!.
Industry RankSector Rank
Dividend Yield N/A

BRIGHTVIEW HOLDINGS INC

NYSE:BV (8/27/2025, 8:04:01 PM)

After market: 14.84 0 (0%)

14.84

+0.23 (+1.57%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-11 2025-11-11/amc
Inst Owners72.37%
Inst Owner Change1.82%
Ins Owners3.06%
Ins Owner Change0.45%
Market Cap1.41B
Analysts80
Price Target19.6 (32.08%)
Short Float %7.41%
Short Ratio5.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.19
Dividend Growth(5Y)N/A
DP511.43%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.42%
Min EPS beat(2)-13.06%
Max EPS beat(2)21.9%
EPS beat(4)2
Avg EPS beat(4)1.55%
Min EPS beat(4)-13.06%
Max EPS beat(4)21.9%
EPS beat(8)3
Avg EPS beat(8)-4.95%
EPS beat(12)6
Avg EPS beat(12)7.79%
EPS beat(16)7
Avg EPS beat(16)3.06%
Revenue beat(2)0
Avg Revenue beat(2)-2.8%
Min Revenue beat(2)-5.2%
Max Revenue beat(2)-0.41%
Revenue beat(4)0
Avg Revenue beat(4)-3.15%
Min Revenue beat(4)-5.2%
Max Revenue beat(4)-0.41%
Revenue beat(8)0
Avg Revenue beat(8)-3.58%
Revenue beat(12)1
Avg Revenue beat(12)-2.88%
Revenue beat(16)2
Avg Revenue beat(16)-2.01%
PT rev (1m)-2.34%
PT rev (3m)-0.25%
EPS NQ rev (1m)-4.81%
EPS NQ rev (3m)-8.21%
EPS NY rev (1m)-6.49%
EPS NY rev (3m)-5.01%
Revenue NQ rev (1m)-1.89%
Revenue NQ rev (3m)-5.97%
Revenue NY rev (1m)-1.74%
Revenue NY rev (3m)-3.11%
Valuation
Industry RankSector Rank
PE 19.03
Fwd PE 16.68
P/S 0.52
P/FCF 43.07
P/OCF 5.4
P/B 0.79
P/tB N/A
EV/EBITDA 7.18
EPS(TTM)0.78
EY5.26%
EPS(NY)0.89
Fwd EY6%
FCF(TTM)0.34
FCFY2.32%
OCF(TTM)2.75
OCFY18.53%
SpS28.44
BVpS18.83
TBVpS-3.19
PEG (NY)1.93
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.21%
ROE 0.39%
ROCE 4.62%
ROIC 3.13%
ROICexc 3.22%
ROICexgc 13.12%
OM 4.88%
PM (TTM) 0.26%
GM 23.25%
FCFM 1.21%
ROA(3y)0.26%
ROA(5y)0.17%
ROE(3y)0.6%
ROE(5y)0.4%
ROIC(3y)2.4%
ROIC(5y)2.06%
ROICexc(3y)2.47%
ROICexc(5y)2.14%
ROICexgc(3y)10.98%
ROICexgc(5y)10.41%
ROCE(3y)3.54%
ROCE(5y)3.05%
ROICexcg growth 3Y-0.5%
ROICexcg growth 5Y-6.24%
ROICexc growth 3Y6.57%
ROICexc growth 5Y-3.78%
OM growth 3Y4.93%
OM growth 5Y-5.36%
PM growth 3Y-27.02%
PM growth 5Y-17.52%
GM growth 3Y-2.9%
GM growth 5Y-2.54%
F-Score5
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 24.18
Debt/EBITDA 2.71
Cap/Depr 142.18%
Cap/Sales 8.46%
Interest Coverage 2.68
Cash Conversion 89.32%
Profit Quality 467.14%
Current Ratio 1.31
Quick Ratio 1.31
Altman-Z 1.5
F-Score5
WACC8.24%
ROIC/WACC0.38
Cap/Depr(3y)57.78%
Cap/Depr(5y)51.34%
Cap/Sales(3y)3.08%
Cap/Sales(5y)2.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.88%
EPS 3Y-14.5%
EPS 5Y-8.19%
EPS Q2Q%-6.25%
EPS Next Y9.87%
EPS Next 2Y8.93%
EPS Next 3Y12.15%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.99%
Revenue growth 3Y2.71%
Revenue growth 5Y2.85%
Sales Q2Q%-4.13%
Revenue Next Year-2.64%
Revenue Next 2Y-0.3%
Revenue Next 3Y1.47%
Revenue Next 5YN/A
EBIT growth 1Y14.04%
EBIT growth 3Y7.78%
EBIT growth 5Y-2.67%
EBIT Next Year77.78%
EBIT Next 3Y27.2%
EBIT Next 5YN/A
FCF growth 1Y-38.76%
FCF growth 3Y13.41%
FCF growth 5Y9.77%
OCF growth 1Y99.92%
OCF growth 3Y11.48%
OCF growth 5Y3.91%